| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jul 17, 2026 | Sell(S) | 4K | $37.90 | $139K | 299K |
| Jul 16, 2026 | Sell(S) | 9K | $36.46 | $334K | 308K |
| Jul 16, 2026 | Sell(S) | 6K | $37.26 | $219K | 303K |
| Jul 16, 2026 | Sell(S) | 19 | $37.96 | $721 | 303K |
| Jul 15, 2026 | Sell(S) | 7K | $36.16 | $259K | 339K |
| Jul 15, 2026 | Sell(S) | 18 | $37.54 | $676 | 318K |
| Jul 15, 2026 | Sell(S) | 8K | $37.04 | $291K | 331K |
| Jul 15, 2026 | Sell(S) | 4K | $36.00 | $161K | 327K |
| Jul 15, 2026 | Sell(S) | 9K | $36.99 | $332K | 318K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0002021233-26-000012) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for MapLight Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.